Protokin therapy in the management of painful bladder syndrome/interstitial cystitis: A pilot study
Phase 2
Recruiting
- Conditions
- Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)N30.1
- Registration Number
- IRCT20130306012728N9
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
All patients with painful bladder syndrome/interstitial cystitis who were resistant to first, second and third line treatment (Botox injection).
Patients who had urodynamic evaluation before injection
Exclusion Criteria
Lack of consent to participate in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method BPIC-SS questionnaire scores. Timepoint: Before and 1 and 3 months after injection. Method of measurement: BPIC-SS questionnaire.;Determining the level of patients' satisfaction with the intervention. Timepoint: Before and 1 and 3 months after injection. Method of measurement: Based on the evaluation checklist, the patient's satisfaction with the procedure is measured from completely satisfied to completely dissatisfied: the evaluated questions include: completely satisfied, somewhat satisfied, dissatisfied, completely dissatisfied.;Determining the amount of side effects in patients. Timepoint: 1 and 3 months after injection. Method of measurement: Checklist for any side effects.
- Secondary Outcome Measures
Name Time Method